The Innovative Drug Development Initiative (IDDI) of the Pulmonary Vascular Research Institute (PVRI)

The Innovative Drug Development Initiative (IDDI) of the Pulmonary Vascular Research Institute (PVRI)

Bibliographic Details
Main Authors:	Paul A Corris, Sylvia Nikkho, Peter Fernandes
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-11-01
Series:	Pulmonary Circulation
Online Access:	https://doi.org/10.1177/2045894020963031

Similar Items

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)
by: David G. Kiely, et al.
Published: (2019-09-01)

Clasificación funcional de la hipertensión pulmonar en niños: informe del task force pediátrico del Pulmonary Vascular Research Institute (PVRI), Panamá 2011 Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011
by: Astrid E Lammers, et al.
Published: (2012-12-01)

Consenso sobre la clasificación de la enfermedad vascular pulmonar hipertensiva en niños: reporte del task force pediátrico del Pulmonary Vascular Research Institute (PVRI) Panamá 2011 A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011
by: María Jesús del Cerro, et al.
Published: (2012-12-01)

Clasificación funcional de la hipertensión pulmonar en niños: Informe del task force pediátrico del Pulmonary Vascular Research Institute (PVRI), Panamá 2011
by: Astrid E. Lammers, et al.
Published: (2012-11-01)

IDDI: integrated domain-domain interaction and protein interaction analysis system
by: Kim Yul, et al.
Published: (2012-06-01)

Consenso sobre la clasificación de la enfermedad vascular pulmonar hipertensiva en niños: Reporte del task force pediátrico del Pulmonary Vascular Research Institute (PVRI) Panamá 2011
by: María Jesús del Cerro, et al.
Published: (2012-11-01)

Clinical trial design in phase 2 and 3 trials for pulmonary hypertension
by: Sylvia Nikkho, et al.
Published: (2020-11-01)

EVENT-DRIVEN STUDIES AND SERIOUS CHRONIC DISEASES: ADDRESSING PLACEBO, DRUG EFFICACY, AND TREATMENT FAILURE IN PULMONARY ARTERY HYPERTENSION
by: Henning Gall, et al.
Published: (2014-10-01)

2020 Annual World Congress of the Pulmonary Vascular Research Institute
Published: (2021-03-01)

Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation
by: Paul Corris, et al.
Published: (2014-12-01)

Repurposing of medications for pulmonary arterial hypertension
by: Mark Toshner, et al.
Published: (2020-10-01)

Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
by: Olivier Sitbon, et al.
Published: (2020-11-01)

The action of drugs in the determination of intrinsic pulmonary vascular mechanisms
by: Alcock, R. P.
Published: (1936)

Improving the trustworthiness, usefulness, and ethics of biomedical research through an innovative and comprehensive institutional initiative.
by: Daniel Strech, et al.
Published: (2020-02-01)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
by: Rui Zhang, et al.
Published: (2020-05-01)

Pulmonary vascular disorders, Progress in respiratory research
by: V K Vijayan
Published: (2013-01-01)

IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial CellsResearch in Context
by: Jie Liu, et al.
Published: (2018-07-01)

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations
by: Seiichiro Sakao, et al.
Published: (2014-09-01)

Sheila “Glennis” Haworth CBE
by: Paul Corris
Published: (2021-01-01)

Recurrent Acute Pulmonary Toxicity and Respiratory Failure Associated with Fludarabine Monophosphate
by: Corey Cutler, et al.
Published: (1997-01-01)

Mechanobiological Feedback in Pulmonary Vascular Disease
by: Paul B. Dieffenbach, et al.
Published: (2018-07-01)

Echocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertension
by: Bergot Emmanuel, et al.
Published: (2010-06-01)

Assessing the innovation capability of a research institution
by: Visser, J. D.
Published: (2011)

Pulmonary vascular responses to hypoxia
by: Talbot, Nicholas
Published: (2004)

The Practice of Innovative Technology Commercialization in Non-profit Research Institute-A Case of T Research Institute
by: Hsun Wang, et al.
Published: (2017)

Updates in pulmonary hypertension and other pulmonary vascular diseases
by: Roberto J. Bernardo, et al.
Published: (2019-09-01)

Pulmonary hypertension and pulmonary vascular disease: course report
by: Andrew Peacock, et al.
Published: (2018-03-01)

Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies
by: Thenappan Thenappan, et al.
Published: (2020-11-01)

Food and drug administration′s critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies
by: Rajiv Mahajan, et al.
Published: (2010-01-01)

Pattern of initial drug resistance and its impact on short course chemotherapy of pulmonary tuberculosis
by: Rai S, et al.
Published: (2007-01-01)

The Evolving Role of the Public Research Institute in Taiwan’s Innovation System: the Case of Industrial Technology Research Institute
by: Shiu, Jyh Wen, et al.
Published: (2015)

The Role of Semaphorin-Neuropilin-1 Signalling in Pulmonary Vascular Development
by: Joza, Stephen Alexander Paul
Published: (2012)

The Role of Semaphorin-Neuropilin-1 Signalling in Pulmonary Vascular Development
by: Joza, Stephen Alexander Paul
Published: (2012)

Open innovation of the research organization －Industrial Technology Research Institute(ITRI)
by: Yi-Feng Chung, et al.
Published: (2009)

The role of prostacyclin and cyclic AMP phosphodiesterases in pulmonary vascular remodelling
by: Phillips, Peter Gerard
Published: (2003)

Institutions, innovation and growth / Institutions, innovation et croissance
by: Spinesi, Luca
Published: (2007)

Treatment of exercise pulmonary hypertension improves pulmonary vascular distensibility
by: William D. Wallace, et al.
Published: (2018-07-01)

Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.
by: Mariana Muñoz-Esquerre, et al.
Published: (2016-01-01)

The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension
by: Charmaine C. W. Lo, et al.
Published: (2018-08-01)

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
by: Jane A. Leopold, et al.
Published: (2016-05-01)

Cannot write session to /tmp/vufind_sessions/sess_nk28ck148dl8t7coe3ac774f3r